Prestige Consumer Valuation
| PBV Stock | EUR 75.00 0.50 0.66% |
At this time, the company appears to be undervalued. Prestige Consumer holds a recent Real Value of €86.44 per share. The prevailing price of the company is €75.0. Our model determines the value of Prestige Consumer from analyzing the company fundamentals such as Return On Equity of 0.13, shares outstanding of 49.69 M, and Operating Margin of 0.31 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Prestige Consumer's price fluctuation is very steady at this time. Calculation of the real value of Prestige Consumer is based on 3 months time horizon. Increasing Prestige Consumer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Prestige stock is determined by what a typical buyer is willing to pay for full or partial control of Prestige Consumer Healthcare. Since Prestige Consumer is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Prestige Stock. However, Prestige Consumer's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 75.0 | Real 86.44 | Hype 75.5 | Naive 74.69 |
The real value of Prestige Stock, also known as its intrinsic value, is the underlying worth of Prestige Consumer Company, which is reflected in its stock price. It is based on Prestige Consumer's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Prestige Consumer's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Prestige Consumer Healthcare helps investors to forecast how Prestige stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Prestige Consumer more accurately as focusing exclusively on Prestige Consumer's fundamentals will not take into account other important factors: Prestige Consumer Total Value Analysis
Prestige Consumer Healthcare is at this time estimated to have takeover price of 4.2 B with market capitalization of 2.82 B, debt of 1.48 B, and cash on hands of 29.04 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Prestige Consumer fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.2 B | 2.82 B | 1.48 B | 29.04 M |
Prestige Consumer Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.87. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prestige Consumer has Price/Earnings To Growth (PEG) ratio of 1.71. The entity last dividend was issued on the 27th of September 2018. Based on the analysis of Prestige Consumer's profitability, liquidity, and operating efficiency, Prestige Consumer Healthcare is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Prestige Consumer Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Prestige Consumer has an asset utilization ratio of 29.61 percent. This implies that the Company is making €0.3 for each dollar of assets. An increasing asset utilization means that Prestige Consumer Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Prestige Consumer Ownership Allocation
Prestige Consumer has a total of 49.69 Million outstanding shares. The majority of Prestige Consumer Healthcare outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Prestige Consumer to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Prestige Consumer. Please pay attention to any change in the institutional holdings of Prestige Consumer as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.Prestige Consumer Profitability Analysis
The company reported the revenue of 1.09 B. Net Income was 205.38 M with profit before overhead, payroll, taxes, and interest of 627.87 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Prestige Consumer's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Prestige Consumer and how it compares across the competition.
About Prestige Consumer Valuation
The stock valuation mechanism determines Prestige Consumer's current worth on a weekly basis. Our valuation model uses a comparative analysis of Prestige Consumer. We calculate exposure to Prestige Consumer's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Prestige Consumer's related companies.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter healthcare products in North America, Australia, and internationally. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. PRESTIGE CONS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 520 people.
8 Steps to conduct Prestige Consumer's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Prestige Consumer's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Prestige Consumer's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Prestige Consumer's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Prestige Consumer's revenue streams: Identify Prestige Consumer's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Prestige Consumer's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Prestige Consumer's growth potential: Evaluate Prestige Consumer's management, business model, and growth potential.
- Determine Prestige Consumer's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Prestige Consumer's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Prestige Stock analysis
When running Prestige Consumer's price analysis, check to measure Prestige Consumer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prestige Consumer is operating at the current time. Most of Prestige Consumer's value examination focuses on studying past and present price action to predict the probability of Prestige Consumer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prestige Consumer's price. Additionally, you may evaluate how the addition of Prestige Consumer to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |